Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
48
|
pubmed:dateCreated |
1991-2-28
|
pubmed:abstractText |
N4-Hydroxy-dCMP (N4-OH-dCMP), N4-methoxy-dCMP (N4-OMe-dCMP), and their 5-fluoro congeners (syntheses of which are described) were all slow-binding inhibitors of Ehrlich carcinoma thymidylate synthase (TS), competitive with respect to dUMP, and had differing kinetic constants describing interactions with the two TS binding sites. N4-OH-dCMP was not a substrate (no dihydrofolate produced; no tritium released with 5-3H-labeled molecule), and its inactivation of TS was methylenetetrahydrofolate-dependent, hence mechanism-based, with arrest of a step posterior to addition of cofactor and blocking abstraction of the C(5) hydrogen. Ki values for N4-OH-dCMP and its 5-fluoro analogue were in the range 10(-7) - 10(-8) M, 2-3 orders of magnitude higher for the corresponding N4-OMe analogues. The 5-methyl analogue of N4-OH-dCMP was 10(4)-fold less potent, pointing to the anti rotamer of the imino form of exocyclic N4-OH, relative to the ring N(3), as the active species. This is consistent with weaker slow-binding inhibition of the altered enzyme from 5-FdUrd-resistant, relative to parent, L1210 cells by both FdUMP and N4-OH-dCMP, suggesting interaction of both N4-OH and C(5)-F groups with the same region of the active center. Kinetic studies with purified enzyme from five sources, viz., Ehrlich carcinoma, L1210 parental, and 5-FdUrd-resistant cells, regenerating rat liver, and the tapeworm Hymenolepis diminuta, demonstrated that addition of a 5-fluoro substituent to N4-OH-dCMP increased its affinity from 2- to 20-fold for the enzyme from different sources.(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/2'-deoxyuridylic acid,
http://linkedlifedata.com/resource/pubmed/chemical/Deoxycytidine Monophosphate,
http://linkedlifedata.com/resource/pubmed/chemical/Deoxyuracil Nucleotides,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorodeoxyuridylate,
http://linkedlifedata.com/resource/pubmed/chemical/N-4-hydroxy-2'-deoxycytidylic acid,
http://linkedlifedata.com/resource/pubmed/chemical/Thymidylate Synthase
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0006-2960
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
4
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
10835-42
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2271682-Animals,
pubmed-meshheading:2271682-Binding, Competitive,
pubmed-meshheading:2271682-Binding Sites,
pubmed-meshheading:2271682-Carcinoma, Ehrlich Tumor,
pubmed-meshheading:2271682-Deoxycytidine Monophosphate,
pubmed-meshheading:2271682-Deoxyuracil Nucleotides,
pubmed-meshheading:2271682-Fluorodeoxyuridylate,
pubmed-meshheading:2271682-Hymenolepis,
pubmed-meshheading:2271682-Kinetics,
pubmed-meshheading:2271682-Leukemia L1210,
pubmed-meshheading:2271682-Liver,
pubmed-meshheading:2271682-Liver Regeneration,
pubmed-meshheading:2271682-Mice,
pubmed-meshheading:2271682-Neoplasms, Experimental,
pubmed-meshheading:2271682-Rats,
pubmed-meshheading:2271682-Thymidylate Synthase,
pubmed-meshheading:2271682-Tumor Cells, Cultured
|
pubmed:year |
1990
|
pubmed:articleTitle |
Mechanism of inhibition of mammalian tumor and other thymidylate synthases by N4-hydroxy-dCMP, N4-hydroxy-5-fluoro-dCMP, and related analogues.
|
pubmed:affiliation |
Nencki Institute of Experimental Biology, Academy of Sciences, Warszawa, Poland.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|